Sources: Generics, Brands Couple REMS Reforms With Part D Measure

By John Wilkerson / September 20, 2018 at 6:35 PM
Sources say brand and generic drug trade groups have agreed in principle on a deal that couples a tweaked version of the generic-backed bill to stop brands from using drug safety requirements to delay competition with brand-backed Part D bills to reduce brands' contribution to beneficiaries' donut-hole costs and avert the so-called coverage gap "cliff." Patients for Affordable Drugs describes the changes in brands' donut-hole contribution as a "fast-moving deal" that would benefit brands at the expense of patients, but...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.